Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v1-EN
Language French English
Date Updated 2019-07-19 2019-05-13
Drug Identification Number 02411407 02411407
Brand name RISEDRONATE-35 RISEDRONATE-35
Common or Proper name RISEDRONATE RISEDRONATE
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients RISEDRONATE SODIUM RISEDRONATE SODIUM
Strength(s) 35MG 35MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Requirements related to complying with good manufacturing practices. Delay in shipping of the drug.
Anticipated start date 2019-05-17 2019-05-17
Actual start date 2019-05-17
Estimated end date 2019-10-04 2019-06-07
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments
Health Canada comments